A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors
Clinical trial NCT04843033 · UNKNOWN
Trial details
- NCT number
- NCT04843033
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-02
- Primary completion
- 2023-10-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.